USPTO serial 99627302
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Danielle I Mattessich
Danielle I Mattessich Merchant & Gould P.C.P.O. Box 2910150 S. Fifth St.Minneapolis, MN 55402| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Aortic arch cannulae; artificial heart-lung machines; cannulae for minimally invasive cardiac surgery; cannulae for pediatric cardiac surgery; centrifugal blood pump system being a medical device to improve outcomes for traditional bypass, mini-bypass and kinetic assist venous drainage; femoral arterial (FA) and femoral venous (FV) cannulae for cannulation of femoral vessels; medical apparatus for cardiac resynchronization; medical apparatus, namely, integrated system heart lung machine disposable to optimize the extra corporeal circulation; medical devices for the treatment of refractory epilepsy and treatment-resistant depression; medical devices involved in the field of cardiac rhythm management solutions, namely, bradyarrhythmia assessment devices, tachyarrhythmia assessment devices, heart failure assessment devices; medical devices involved in the field of neuromodulation, namely, medical apparatus consisting of a non-implantable modulating frequency generator, providing neuromodulation therapy to cranial and peripheral nerves, medical apparatus consisting of a non-implantable modulating frequency generator and implantable needle arrays for transmitting current into auricular and peri-auricular tissue for use in pain management, namely, patient stimulators for auricular and peri-auricular peripheral nerve in the field of neuromodulation therapy, implantable batteries for neuromodulation, implantable neuromodulation device that delivers a high frequency electrical signal for use in chronic pain, motor control, spasticity, and autonomic nervous system applications; medical devices, namely, endoscopic vessel harvesting apparatus and replacement accessories sold therewith as a unit; medical implants including programmable pulse generators and leads used for the control of neurological disorders and neurological and muscle stimulators and related control equipment; monitors for blood parameters in ECC (extracorporeal circulation); Oxygenators being medical devices; patient membrane oxygenator being medical devices; and structural parts therefor; Pediatric medical devices, namely, pediatric hollow fiber oxygenators and pediatric arterial filters; perfusion medical devices, namely, heart monitors and respiration monitors, and replacements parts for the monitors, perfusion medical devices comprised of power supply units, roller pumps and monitoring device for perfusion systems, and replacement parts for perfusion medical devices; perfusion tubing medical devices; pericardiac sump pumps being medical devices; portable cardiopulmonary bypass medical devices; portable medical devices for extracorporeal circulation and autotransfusion; 4 radio frequency programming and telemetry decoders for use with medical implants; suction wands and intracardiac suckers in the nature of wound suction apparatus; surgical apparatus and instruments for medical use; venous return cannulae; all the above for medical and surgical use | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 3, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 3, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 3, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 4, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 4, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 4, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 29, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| May 26, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 1, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 1, 2026 | NWAP | NEW APPLICATION ENTERED | — |